Pradeep Kulkarni
Pulmonary Disease · Springfield, ILNPI 1609828292
Payments from drug & device makers
Across 82 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$254
- Regeneron Healthcare Solutions, Inc.$159
- Jazz Pharmaceuticals Inc.$152
- Insmed, Inc.$110
- Genentech USA, Inc.$108
- Pfizer$70
- plus $632 from 17 others
What the payments were for
- Food & beverage$1,485100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $254 |
| Regeneron Healthcare Solutions, Inc. | 6 | $159 |
| Jazz Pharmaceuticals Inc. | 5 | $152 |
| Insmed, Inc. | 5 | $110 |
| Genentech USA, Inc. | 7 | $108 |
| Pfizer | 6 | $70 |
| CSL Behring | 5 | $66 |
| Sunovion Pharmaceuticals Inc. | 8 | $63 |
| E.r. Squibb & Sons, L.L.C. | 1 | $54 |
| Grifols USA, LLC | 3 | $53 |
| GSK | 3 | $51 |
| Shire North American Group Inc | 3 | $46 |
| Amgen(2 entities) | 2 | $40 |
| Harmony Biosciences LLC | 3 | $39 |
| Boehringer Ingelheim | 3 | $38 |
| Tersera Therapeutics LLC | 2 | $30 |
| Seqirus USA Inc | 2 | $26 |
| Sanofi | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Circassia Inc. | 2 | $23 |
| Electromed, Inc. | 2 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMBICORT$152
- BEVESPI AEROSPHERE$152
- FASENRA$152
- FARXIGA$152
How this compares
$1,485 in reported general payments places this provider in the 45th percentile of 539 pulmonary disease providers in Illinois.
Other pulmonary disease in Springfield
- Douglas HogarthChicago$3.1M
- Manu JainChicago$1.9M
- Momen WahidiChicago$1.2M
- Shashi BellamEvanston$1.2M
- Marilyn GlassbergMaywood$1000K
- Steven WhiteChicago$989K
- Ravi KalhanChicago$831K
- Patrick WhittenPeoria$812K
- Jane Dematte DamicoChicago$811K
- Septimiu MurguChicago$804K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.